Market Reports

Making a difference in pharma contract manufacturing

Making a difference in pharma contract manufacturing

With a plant near Basel, Switzerland, and a heritage of more than 40 years, contract service provider Legacy Pharmaceuticals understands the value of flexibility and experience when producing parenteral and semisolid drugs. Dr Kevin Robinson spoke to Mike Danzi, Chief Executive Officer, to find out more
Continuously driving pharmaceutical manufacturing efficiencies

Continuously driving pharmaceutical manufacturing efficiencies

Continuous manufacturing has long been accepted by a host of manufacturing industries from food and beverage to oil and gas, where it ensures the delivery of a consistent and continuous quality of product
Health experts reveal 10 most important medicines in NHS history

Health experts reveal 10 most important medicines in NHS history

Antipsychotics, breast cancer drug, oral contraceptives and MMR vaccine make the top 10
Brexit trade bill: Not yet

Brexit trade bill: Not yet

The UK has decided it will continue to be involved with the European Medicines Agency (EMA) after Brexit. Paul Brooks, Executive Director at the Regulatory Affairs Professionals Society (RAPS) asks what does this mean for the pharmaceutical industry and patients after 2020?
Maintenance across borders

Maintenance across borders

Here, Dave Friar, International Operations Director at Boulting, international engineering solutions provider, considers what you should do when preparing to hand over maintenance control on an overseas project
Treating chronic wounds with live biotherapeutics

Treating chronic wounds with live biotherapeutics

Angharad Baldwin talks to Evelina Vågesjö, CEO, and Peter Frank, Drug Development Manager, of Swedish biologics company, Ilya Pharma, about using live bacteria to treat chronic wounds
Isolator sterility put to the test

Isolator sterility put to the test

Sterility testing must be carried out under strict aseptic conditions. Stacey Orley, Wickham Laboratories, describes the process to ensure products and devices are contaminant-free
A new way of buying and selling APIs, additives, vitamins and excipients

A new way of buying and selling APIs, additives, vitamins and excipients

Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and nutritional ingredients
The nanozyme that uses light to kill bacteria

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge potential applications. Angharad Baldwin interviews Professor Vipul Bansal, lead researcher, to find out more
Six months and counting

Six months and counting

With 6 months to go until the DSCSA serialisation enforcement deadline kicks in, <i>Manufacturing Chemist</i> caught up with some leading lights in the industry to find out how companies were shaping up ahead of November to mark the occasion
Invisible benefits

Invisible benefits

SCHOTT enhances its iQ platform with the introduction of the new syriQ BioPure glass syringe for sensitive drugs
Accelerating drug discovery

Accelerating drug discovery

Angharad Baldwin of <i>Manufacturing Chemist</i> speaks to Dr Trevor Perrior, CSO of Domainex, about the development of a new GPCR drug discovery technology
The final countdown: CDMO focus areas before Feb 2019

The final countdown: CDMO focus areas before Feb 2019

Staffan Widengren will be presenting at <a href='https://www.tracelink.com/futurelink'>FutureLink Munich</a> on the <i>Final countdown: focus areas for a CDMO before February 2019</i>
How to boost the conversion rate of your e-commerce website in the manufacturing industry

How to boost the conversion rate of your e-commerce website in the manufacturing industry

Fifty three per cent of businesses spend less than 5% of their total marketing budget on boosting their conversion rates, and 35% of businesses have a conversion rate of less than 1%
Advances in medical technology

Advances in medical technology

Overhauling operating models to create digital value
Tailor-made molecules for the drugs of tomorrow

Tailor-made molecules for the drugs of tomorrow

Getting a drug to market is no easy feat, especially with tight regulations to comply with and the plethora of products that are already available. This is why a service that streamlines the discovery process and leads to improved outcomes during clinical trials for drug candidates is likely to be very desirable

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    How onco-HPAPI manufacturing is adapting to a new era The oncology landscape is undergoing a quiet but powerful shift. Pharmaceutical companies, once focused primarily on novel compounds, are now increasingly exploring repurposing opportunities with existing high-potency oncology APIs (onco-HPAPIs)
  2. The economic advantages of continuous flow chemistry Batch production has been the traditional workhorse of the pharmaceutical manufacturing sector. However, economic advantages are taking continuous flow out of the realm of a niche technology for high energy, hazardous reactions to become an essential part of the small molecule manufacturing toolkit
  3. Addressing glass particulates in injectable drug formulations Glass particles are a frequent contaminant risk when producing injectable drugs on high speed filling lines. Glassmaker Corning has studied the root causes and engineered a new glass product for use on existing equipment that significantly reduces that risk
  4. Using ddPCR to accurately quantify AAV viral titre and integrity Gene therapy is primed to become the next major development in medicine and bring relief to patients living with diseases ranging from haemophilia to Alzheimer’s disease, write Mark White, Associate Director of Biopharma Product Marketing, and Marwan Alsarraj, Biopharma Segment Manager, Bio-Rad
  5. Host cell protein analysis: strategies to improve sensitivity and reproducibility Given that the US FDA approved 25 new cellular and gene therapy products in 2022, gene-based vaccines and therapeutics have now entered the mainstream pharmaceutical industry. However, the rising interest in gene-based strategies puts pressure on manufacturers to demonstrate optimum efficacy and safety

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all